n(omega)-hydroxyarginine has been researched along with benzamidoxime in 1 studies
| Studies (n(omega)-hydroxyarginine) | Trials (n(omega)-hydroxyarginine) | Recent Studies (post-2010) (n(omega)-hydroxyarginine) | Studies (benzamidoxime) | Trials (benzamidoxime) | Recent Studies (post-2010) (benzamidoxime) |
|---|---|---|---|---|---|
| 139 | 0 | 24 | 32 | 0 | 11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bittner, F; Clement, B; Garbe-Schönberg, D; Havemeyer, A; Kotthaus, J; Mendel, R; Schade, D; Wahl, B | 1 |
1 other study(ies) available for n(omega)-hydroxyarginine and benzamidoxime
| Article | Year |
|---|---|
Reduction of N(ω)-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC).
Topics: Animals; Arginine; Benzamidines; Hep G2 Cells; Humans; Mitochondrial Proteins; Oxidation-Reduction; Oxidoreductases; Swine | 2011 |